Transgene Biotek Limited (BOM:526139)

Transgene Biotek Revenue

Transgene Biotek had revenue of 545.00K INR in the quarter ending December 31, 2025, a decrease of -28.76%. This brings the company's revenue in the last twelve months to 2.33M, up 1.73% year-over-year. In the fiscal year ending March 31, 2025, Transgene Biotek had annual revenue of 2.61M with 10.98% growth.

• Revenue (ttm): 2.33M
• Revenue Growth: +1.73%
• P/S Ratio: 103.97
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 242.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.61M	258.00K	10.98%
Mar 31, 2024	2.35M	1.80M	326.32%
Mar 31, 2023	551.00K	-315.95K	-36.44%
Mar 31, 2022	866.95K	-828.55K	-48.87%
Mar 31, 2021	1.70M	1.66M	4,642.12%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error